Monongahela Capital Management »

Novo Nordisk A/S shares owned by Monongahela Capital Management

Quarter-by-quarter ownership of Novo Nordisk A/S (NVO) shares owned by Monongahela Capital Management from 13F filings

Historical chart of Monongahela Capital Management investment in Novo Nordisk A/S

Tip: Access up to 7 years of quarterly data

All positions including Novo Nordisk A/S held by Monongahela Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Novo Nordisk A/S by Monongahela Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.4M 47k 50.88

More positions owned by Monongahela Capital Management

Coherent Corp (COHR)
Eli Lilly & Co. (LLY)
Abbvie (ABBV)
Williams-Sonoma (WSM)
Microsoft Corporation (MSFT)
Emerson Electric (EMR)
Rockwell Automation (ROK)
Abbott Laboratories (ABT)
Procter & Gamble Company (PG)
Badger Meter (BMI)
Merck & Co (MRK)
Johnson & Johnson (JNJ)
American Express Company (AXP)
Apple (AAPL)
Hubbell (HUBB)

View all positions for Monongahela Capital Management

Top funds holding Novo Nordisk A/S

Citadel Advisors
Loomis, Sayles and
Susquehanna International
Franklin Resources
FMR
Jane Street
Goldman Sachs Group
Capital Research and Management Company - Division 3
Folketrygdfondet
Fisher Investments
UBS Group
Everett Harris & Co
State Farm Mutual Automobile Insurance Company
State Street Corporation
Jpmorgan Chase & Co

View all funds holding Novo Nordisk A/S